You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Castration-resistant

Showing 26 - 50 of 5,795
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration Resistant Prostate Cancer Trial in China (AC176)

Not yet recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Beijing, China
  • +4 more
Jan 4, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Feb 28, 2023

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Mar 28, 2023

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

PRostate Olaparib Real World Evidence Study

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Sep 4, 2023

    Castration Resistant Prostate Cancer Trial run by the National Cancer Institute (NCI) (Bintrafusp alfa, N-803, BN-Brachyury)

    Not yet recruiting
    • Castration Resistant Prostate Cancer
    • Bintrafusp alfa
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Called DEAR, to Learn More About Treatment With Darolutamide,

    Active, not recruiting
    • Non-metastatic Castration-resistant Prostate Cancer
    • Darolutamide (Nubeqa, BAY1841788)
    • +2 more
    • Whippany, New Jersey
      Bayer
    Jan 13, 2023

    Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)

    Not yet recruiting
    • Castration-resistant Prostate Cancer
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Sep 6, 2022

    Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

    Not yet recruiting
    • Castration Resistant Prostate Cancer
    • Castration Sensitive Prostate Cancer
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jun 16, 2023

    Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +7 more
    • Biopsy
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Prostate Cancer Trial in Tampa (Abiraterone Acetate)

    Active, not recruiting
    • Prostate Cancer
    • Abiraterone Acetate
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 3, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Aug 16, 2023

    Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

    Recruiting
    • Castration-Resistant Prostatic Cancer
    • +4 more
    • Orange City, Florida
    • +1 more
    Nov 23, 2022

    Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (177Lu-PSMA-617, PSMA-11)

    No longer available
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 12, 2023

    Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • mCRPC
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Jul 20, 2022

    Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)

    Not yet recruiting
    • Prostatic Neoplasms
    • Castration-Resistant
    • Brisbane, Queensland, Australia
      Royal Brisbane & Women's Hospital
    Feb 9, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Tianjin (TABP EIC, Cyclophosphamide, fludarabine)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • TABP EIC
    • +2 more
    • Tianjin, China
      Tianjin pepole's hosptial
    Jul 28, 2022

    Prostate Cancer, Castration-resistant Prostate Cancer Trial in São Paulo (Docetaxel, Enzalutamide)

    Active, not recruiting
    • Prostate Cancer
    • Castration-resistant Prostate Cancer
    • São Paulo, SP, Brazil
      Instituto do Câncer do Estado de São Paulo
    Sep 14, 2022

    Metastatic Castration Resistant Prostate Cancer Trial in Shanghai (Fluzoparib, Enzalutamide OR abiraterone acetate With

    Active, not recruiting
    • Metastatic Castration Resistant Prostate Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Sep 23, 2022

    Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

    Recruiting
    • Prostate Cancer
    • Prostate Cancer Metastatic
    • La Jolla, California
    • +1 more
    Feb 2, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in San Francisco, Providence (Rucaparib, Copanlisib)

    Active, not recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • San Francisco, California
    • +1 more
    Nov 22, 2022

    Metastatic Castration-resistant Prostate Cancer Trial (Pembrolizumab, Enzalutamide)

    Completed
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Aug 16, 2022

    Prostate Cancer, Refractory Cancer, Castration Resistant Prostatic Cancer Trial in Winston-Salem (Omeprazole 80 mg twice daily)

    Recruiting
    • Prostate Cancer
    • +2 more
    • Omeprazole 80 mg twice daily
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Jan 5, 2023

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

    Active, not recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • Abiraterone Acetate
    • +2 more
    • Los Angeles, California
    • +6 more
    Jan 18, 2023